Last quarter (Q0 0), Revive Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Revive Therapeutics's net income was $―. See Revive Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Total Revenue	$ ―	$ ―	$ -405.38K	$ -321.36K	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ -405.38K	$ -321.36K	$ ―	$ ―
Operating Expense	$ 3.06M	$ 3.31M	$ 5.52M	$ 17.58M	$ 18.59M	$ 3.68M
Operating Income	$ -3.06M	$ -3.31M	$ -5.52M	$ -17.90M	$ -18.59M	$ -3.68M
Net Non Operating Interest Income Expense	$ 38.67K	$ 45.58K	$ -64.61K	$ 62.20K	$ -17.75K	$ 42.17K
Other Income Expense	$ 16.62K	$ 10.27K	$ -864.50K	$ -34.27K	$ -1.54M	$ -1.66M
Pretax Income	$ -3.03M	$ -5.62M	$ -6.32M	$ -17.81M	$ -20.12M	$ -5.38M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -3.03M	$ -5.62M	$ -6.32M	$ -17.81M	$ -20.12M	$ -5.38M
Basic EPS	$ ―	$ -0.01	$ -0.02	$ -0.06	$ -0.08	$ -0.05
Diluted EPS	$ ―	$ -0.01	$ -0.02	$ -0.06	$ -0.08	$ -0.05
Basic Average Shares	$ 1.10B	$ 380.48M	$ 339.37M	$ 319.76M	$ 267.49M	$ 106.88M
Diluted Average Shares	$ 1.10B	$ 380.48M	$ 339.37M	$ 319.76M	$ 267.49M	$ 106.88M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 3.06M	$ 3.31M	$ 5.52M	$ 17.58M	$ -18.59M	$ -3.68M
Net Income From Continuing And Discontinued Operation	$ -3.03M	$ -5.62M	$ -6.32M	$ -17.81M	$ -20.12M	$ -5.38M
Normalized Income	$ -2.23M	$ -3.22M	$ -3.87M	$ -13.06M	$ -13.06M	$ -3.96M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -3.02M	$ -5.62M	$ -6.28M	$ -17.81M	$ -20.04M	$ -5.29M
EBITDA	$ -3.02M	$ -5.62M	$ -6.28M	$ -17.81M	$ -20.04M	$ -5.27M

Currency in USD

Revive Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing